Analysts are making fresh calls across sectors this Monday. Two chemicals giants took hits. Target prices fell for both DOW and LYB. Dow's average target slipped to $41.50. LyondellBasell's dropped to $78.41. Both names sit in a sector facing margin pressure from weak global demand.
Medical devices moved the other way. Edwards Lifesciences saw its consensus target nudge up to $97.31. The heart valve maker carries a $52bn market cap. Short interest is just 2.1% of free float — bears are not piling in.
The most striking action came at Honeywell. An analyst removed their recommendation entirely. The consensus target dropped sharply to $229, down from a prior $486. That is a dramatic revision for a $147bn industrial giant. It likely reflects Honeywell's ongoing breakup into three separate businesses.
Capital One picked up a target upgrade to $256. KKR also gained, with its target moving to $126. Both financials benefit from the current rate environment.
Walt Disney got a target bump to $129.94. The stock carries 26 sell recommendations — the bullish camp remains thin despite recent streaming gains.
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
